Home
About Journal
Editorial Board
Instruction
Subscribe
Download
Contact Us
Chinese
中国医学创新
2023
,
Vol. 20
Issue (23)
: 40-44
DOI
: 10.3969/j.issn.1674-4985.2023.23.010
Clinical research
Current Issue
|
Archive
|
Adv Search
|
Clinical Efficacy and Safety of Intravenous Thrombolysis in the Treatment of High-risk Non-disabling Ischemic Stroke
JIANG Qian
First-author's address: Yichun People's Hospital, Jiangxi Province, Yichun 336000, China
Abstract
Figure/Table
References
Related Citation (15)
Download:
PDF
(1030 KB)
HTML
(1 KB)
Export:
BibTeX
|
EndNote
(RIS)
Received:
30 December 2022
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
JIANG Qian
Cite this article:
JIANG Qian. Clinical Efficacy and Safety of Intravenous Thrombolysis in the Treatment of High-risk Non-disabling Ischemic Stroke[J]. 中国医学创新, 2023, 20(23): 40-44.
URL:
http://www.zgyxcx.com/EN/10.3969/j.issn.1674-4985.2023.23.010
OR
http://www.zgyxcx.com/EN/Y2023/V20/I23/40
[1]
CUI Bo.
Clinical Effect of Shenqi Naokang Capsules Combined with Ganglioside Sodium Injection on Patients with Acute Brain Injury and Its Influence on the Levels of Neurocytokines, suPAR, IGF-Ⅱ and UCH-L1
[J]. 中国医学创新, 2023, 20(9): 36-40.
© 2016 中国医学创新 editorial
Address: Beijing south cellular road number five Postcodes: 100055